Incysus Therapeutics Inc. announced the appointment of Lawrence S. Lamb, PhD as Executive Vice President and Chief Scientific Officer. Dr. Lamb will lead the company’s research and development programs and will be responsible for setting scientific strategy. Dr. Lamb has been working with the company since early 2016; his experience and leadership as the scientific co-founder of the Company has guided Incysus in the development of scientific advancements in cancer treatments. Prior to joining the company full time, Dr. Lamb was a Professor of Medicine in the Division of Hematology and Oncology and the Director of the Cell Therapy Laboratory for the Blood and Marrow Transplantation and Cell Therapy Program at the University of Alabama Birmingham’s (UAB) School of Medicine. He also had academic appointments in the Departments of Pathology and Pediatrics and as a Senior Scientist in the UAB Comprehensive Cancer Center.